Carregant...

Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis

BACKGROUND: Immunosuppressive therapy may potentially alter the natural disease course of scleroderma. There have been reports of using mycophenolate mofetil (MMF) for the treatment of scleroderma skin disease. OBJECTIVE: To analyse the experience of using MMF for the treatment of active diffuse cut...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Le, Elizabeth N, Wigley, Fredrick M, Shah, Ami A, Boin, Francesco, Hummers, Laura K
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3828653/
https://ncbi.nlm.nih.gov/pubmed/21378404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2010.142000
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!